about
The Evolution of Cystic Fibrosis CareSLC transporters as therapeutic targets: emerging opportunitiesColistimethate sodium for the treatment of chronic pulmonary infection in cystic fibrosis: an evidence-based review of its place in therapyThe elements of life and medicinesNanotechnology approaches for inhalation treatment of fibrosis.Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis.Hypertonic saline releases the attached small intestinal cystic fibrosis mucusMicrobiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation.GBA2-encoded β-glucosidase activity is involved in the inflammatory response to Pseudomonas aeruginosa.Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis.Pseudomonas aeruginosa biofilms in disease.Paediatric gastrointestinal conditions and their oral implications.Ivacaftor treatment of cystic fibrosis patients with the G551D mutation: a review of the evidence.A reciprocating twin-channel model for ABC transporters.Efficacy and adverse effects of drugs used to treat adult cystic fibrosis.Clinical and in vitro evidence for the antimicrobial therapy in Burkholderia cepacia complex infections.Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosisPharmacogenetics of cystic fibrosis treatment.Cystic fibrosis: a clinical view.The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channel.Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.Hypoxia, receptor for advanced glycation end products, and cystic fibrosis: a pathway to chronic inflammation?Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.Editorial: Advances in Pediatric Pulmonology.Bicarbonate Inhibits Bacterial Growth and Biofilm Formation of Prevalent Cystic Fibrosis Pathogens
P2860
Q26999299-667279F7-B60F-48F9-881D-77C9C37C14B7Q27014726-B800BB9C-42D7-4520-8513-E122226F2933Q27014993-AFAFA8A3-E36A-4335-98EA-70405516A662Q28649323-5B73A65D-DF89-4AB7-B26D-C256CB250ED6Q34449624-C217DFEA-83A2-48F2-9F91-D84F92043EF9Q34748891-2CA25D6E-7973-463F-907E-6AA477700E08Q35004229-E0843C74-A243-425F-BF61-5311B9C4A125Q35072759-77B6B4A3-B8EB-4456-90B7-7DC029429E37Q35228672-4A429DE9-8554-4728-8439-A282A5EF455DQ36108378-B0798AEC-D6F9-422D-B7D2-825253D8004BQ37687126-9F253468-CBB0-4D73-A6BE-E9F3FBD5F22CQ38129088-F22AE77E-EEFA-45C2-ACC6-425B740C808AQ38134182-44C44090-655D-4E6D-A4EA-879AC27D9F8AQ38208521-06A2A206-9906-435B-94FB-F015474C6784Q38325672-3DC166BD-5AE6-4326-8509-F0BE547B043CQ38378454-9E804742-96DD-4AF1-8425-5CBCE4AF1395Q38708247-A6A120B4-01A7-4E0D-9671-387D1EBF96DFQ38918082-B8B7D0B7-90C0-4AE7-990E-580B9E214DB1Q38973292-C7AB1C9A-74ED-4C0A-8E95-694F7868690EQ39077956-986D5666-C5C8-4720-8A15-4205AA074F4FQ44909879-05F3F03B-4FC5-47B3-A240-F3906239BE09Q45031309-6BED5EDD-663B-40EC-9336-A0E12B7BDB9CQ47781166-7C5002ED-611E-4E85-9DDC-F50C6784A894Q51620535-480E9469-50A8-449B-B247-DA6C93240603Q57072769-E6F546E8-7E77-49CF-8462-05F5FC717549
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cystic fibrosis therapeutics: the road ahead
@ast
Cystic fibrosis therapeutics: the road ahead
@en
Cystic fibrosis therapeutics: the road ahead
@nl
type
label
Cystic fibrosis therapeutics: the road ahead
@ast
Cystic fibrosis therapeutics: the road ahead
@en
Cystic fibrosis therapeutics: the road ahead
@nl
prefLabel
Cystic fibrosis therapeutics: the road ahead
@ast
Cystic fibrosis therapeutics: the road ahead
@en
Cystic fibrosis therapeutics: the road ahead
@nl
P2860
P356
P1433
P1476
Cystic fibrosis therapeutics: the road ahead
@en
P2093
Bonnie W. Ramsey
Lucas R. Hoffman
P2860
P304
P356
10.1378/CHEST.12-1639
P407
P577
2013-01-01T00:00:00Z